Home › Funds › Point72 Asset Management › IMVT
Point72 Asset Management position in IMVT
IMMUNOVANT INC · Health Care
Latest position (Q4 2025)2.00M sh
Reported value held$50.84M
Portfolio Weight0.06%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 900.50K | $7.67M | New |
| Q1 2022 | 459.30K | $2.53M | Reduce |
| Q3 2022 | 1.97M | $10.98M | New |
| Q4 2022 | 435.75K | $7.73M | Reduce |
| Q2 2023 | 457.47K | $8.68M | New |
| Q4 2023 | 2.67M | $112.36M | New |
| Q1 2024 | 1.38M | $44.71M | Reduce |
| Q1 2025 | 801.93K | $13.70M | New |
| Q2 2025 | 3.34M | $53.38M | Add |
| Q3 2025 | 3.44M | $55.49M | Add |
| Q4 2025 | 2.00M | $50.84M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMVT
- Fidelity Management & Research (FMR) 16.19M sh · $623.66M · Q2 2026
- BlackRock Inc 7.18M sh · $276.68M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- Vanguard Group 7.78M sh · $197.75M · Q4 2025
- Morgan Stanley 4.53M sh · $174.73M · Q2 2026
- Geode Capital Management 2.23M sh · $86.12M · Q2 2026
- Goldman Sachs Group 1.75M sh · $67.47M · Q2 2026
- D. E. Shaw & Co 1.24M sh · $47.80M · Q2 2026
- Bank of America Corp 1.18M sh · $45.52M · Q2 2026
- Northern Trust Corp 794.00K sh · $30.59M · Q2 2026
- Renaissance Technologies 726.80K sh · $28.00M · Q2 2026
- Charles Schwab Investment Management 680.59K sh · $26.22M · Q2 2026